News & Events

Paradigm4 Launches Precision Cell Atlas™
Paradigm4 has launched the Precision Cell AtlasTM as an integral component of its REVEALTM: SingleCell app. The Precision Cell Atlas enables scientists to create a ... » FULL ARTICLE
Pharma’s Almanac || What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Marilyn Matz, Chief Executive Officer and Co-Founder, Paradigm4 “Genomics’ role in the life science vision “is only as credible as its implementation,” » FULL ARTICLE
Paradigm4 Launches REVEAL: Proteomics to Transform the Search for Protein Isoform Biomarkers
BOSTON — Paradigm4 has today unveiled REVEAL™: Proteomics, the newest use case specific app powered by the Paradigm4 FLASH™ high-performance bioinformatics platform. REVEAL: Proteomics unlocks ... » FULL ARTICLE
insideBIGDATA || Big Data in Life Sciences – Why ‘doing things the old way’ is the Biggest Barrier to Progress
Zachary Pitluk, Ph.D., Vice President of Life Sciences and Healthcare at Paradigm4, highlights how real insight comes, not from data collection, but from intelligent data ... » FULL ARTICLE
Bio-IT World || The Role Of Bioinformatics In Bringing Biobanks To The Forefront Of Scientific Breakthroughs
Life science researchers and drug discovery scientists today work in what, in my view, will be remembered in the future as the beginning of a ... » FULL ARTICLE
Biospace || Paradigm4 Joins the Tetra Partner Network to Leverage Tetra Data into High-performing Analytical Computing Applications for Pharmaceutical Customers
TetraScience, the R&D Data Cloud company, announced today that Paradigm4, an integrated scientific data analytics company, has joined the Tetra Partner Network (TPN) so that ... » FULL ARTICLE
International Pharmaceutical Technology | 1 Trillion Cells, 50 Million Individuals
Calculating the true value of scientific data storage platforms is the goal of every developer. With millions of cells to analyze, digital solutions are the ... » FULL ARTICLE
Paradigm4 launches flexFS
Paradigm4, an integrated scientific data analytics company, has launched flexFS, its elastic cloud file system for flexible and more resource-efficient data storage and scalable computing. » FULL ARTICLE
Pharma’s Almanac | What do you think most differentiates the U.S. pharma/biopharma industry or the market?
Paradigm4’s Marilyn Matz reflects on the understanding complex biological phenomena has required concurrent advances in experimental methods and computing power. » FULL ARTICLE
Pharma’s Almanac | Integrating Heterogeneous Data to Enable Precision Medicine
Paradigm4’s Marilyn Matz and Zachary Pitluk discuss the challenges of integrating data from heterogeneous sources and how the company’s plaform and apps combine the cutting ... » FULL ARTICLE
Manufacturing Chemist | Multidimensional data analysis platforms: meeting new FDA calls for consistent evidence from CGT developers
Recent news that the US Food and Drug Administration (FDA) will ask cell and gene therapy (CGT) developers to provide more consistent evidence with their ... » FULL ARTICLE
Proteomics & Metabolomics | Paradigm4 Launches REVEAL: Multi-Omics App for Advanced Cross-Study Analyses
Paradigm4 has launched its REVEAL™: Multi-Omics app, allowing researchers to undertake advanced, cross-study analyses and enable quick searches for genes and proteins across all integrated ... » FULL ARTICLE
Biocompare | Are We Ready to Embrace Precision Medicine?
Precision medicine is one of the most talked about trends in healthcare. The promise is improved health outcomes and patient satisfaction, gained through an understanding ... » FULL ARTICLE
Drug Discovery World | Are scalable data science platforms the way forward?
Marilyn Matz, CEO of Paradigm4, and Zachary Pitluk, Vice President of Life Sciences at Paradigm4, explain why scalable data science platforms are key to supporting ... » FULL ARTICLE
Clinical Omics | Pushing the Proteomics envelope
 More sensitive technology spurs proteomic and metabolomic biomarker identification, clinical use. (Complete article on page 21) » FULL ARTICLE
Clinical Laboratory | Paradigm4 unveils analytical development data management tool to unlock Allotrope data format (ADF) ‘treasure trove’
Addressing the vital economic challenge of uncovering new critical quality attributes (CQAs), Paradigm4’s REVEALTM Analytical Development app enables data analysts… » FULL ARTICLE
datanami | Key Questions to Ask of Your Scientific Data Platform for Single Cell Analysis
The idea of precision medicine – delivering the right drug treatment to the right patient at the right time and at the right dose – ... » FULL ARTICLE
R&D World | The need for next generation analytics to extract valuable insights from genomic biobank data
Precision medicine is poised to transform healthcare, with biobanks being identified as a key enabler to bring it to fruition by 2030 by putting new, ... » FULL ARTICLE
GEN: Genetic Engineering and Biotechnology News | The Vast Potential of Single-Cell Analysis
Single-cell analysis has great promise… but how can we get there? by Zachary Pitluk » FULL ARTICLE
Genentic Engineering & Biotechnology News | AI in Drug Discovery Starts to Live Up to the Hype
The past few years have seen several flashy demonstrations of how artificial intelligence (AI) algorithms may transform biomedical research, particularly with respect to drug discovery. » FULL ARTICLE
The Analytical Scientist | The Vast Potential of Single-Cell Analysis
Single-cell analysis has great promise… but how can we get there? by Zachary Pitluk » FULL ARTICLE
54 Gene enlists Paradigm4 app for African Health Information Ecosystem
Paradigm4 has signed an agreement with 54Gene allowing the latter to use the former’s Reveal Biobank App to explore, characterise and query 54Gene’s African Health ... » FULL ARTICLE
BIO-IT World | Is Precision Medicine Ready For Data From Billions Of Cells?
Popular opinion is that two big shifts have changed the game for bioinformatics. The first is a technology development—single cell ‘omics—that began just over 10 ... » FULL ARTICLE
Technology Networks | How Can Data Platforms Unlock the Power of Single-Cell Analysis?
Single-cell technologies have positioned themselves at the forefront of biomedical research. These platforms allow researchers to bypass the uncertainties of bulk data and instead interrogate ... » FULL ARTICLE
Manufacturing Chemist | The increasing power of single-cell omics: changing the future of medicine
Advances in the single-cell genomic analysis of cells and tissues, including the required computational methods, have now put systematic, high-resolution and comprehensive reference maps of ... » FULL ARTICLE
54gene Enlists Paradigm4’s Science-Ready Data Solution for its African Health Information Ecosystem
12 JANUARY 2021: Paradigm4, specialist in scientific data management and scalable computation, has signed an agreement with 54gene, a health technology company deriving insights from the world’s ... » FULL ARTICLE
Technology Networks | How Can Data Platforms Unlock the Power of Single-Cell Analysis?
Single-cell technologies have positioned themselves at the forefront of biomedical research. These platforms allow researchers to bypass the uncertainties of bulk data and instead interrogate ... » FULL ARTICLE
Pharma’s Almanac | Enabling Pharma Researchers to Think Differently with Effective Data Manipulation
Pharma researchers are tasked with organizing disparate data, which detracts from time spent understanding disease mechanisms and enabling the development of more effective drugs. Paradigm4 ... » FULL ARTICLE
GenomeWeb: Paradigm4 Moves Into Single-Cell Data, Helps Pharma Address COVID-19
Neil Versel » FULL ARTICLE
Allotrope Connect Fall 2020 Conference presentation: Leveraging millions of ADF files and enabling Data Science in Pharma with Python and R
Zach Pitluk, Ph.D. » FULL ARTICLE
BioPharma Trend: A new way to work with data in life sciences
Interview with Marilyn Matz, CEO and Co-founder at Paradigm4, and 2020 NACD Directorship 100™ honoree, and her colleague Dr. Zachary Pitluk, VP of Life Sciences ... » FULL ARTICLE
AWS Healthcare & Life Science (HCLS) Web Day 2020
Oh the Places You’ll Go (with 1 billion regressions an hour) explores the partnership with Alnylam to access and understand the data from the UK ... » FULL ARTICLE